3D Tissue

Shares of Organovo (NYSE: ONVO) gained more than 12 percent following the company's regulation FD disclosure. In an 8-K filing on Thursday, Organovo reported positive results from a collaborative study using the company's 3D Human Liver Tissues. The filing states, "Dr. Adrian...